Bank of America’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$109M Sell
1,023,114
-479,167
-32% -$58M 0.01% 1122
2026
Q1
$246M Sell
1,502,281
-223,400
-13% -$34.3M 0.02% 633
2025
Q4
$300M Buy
1,725,681
+123,875
+8% +$22.6M 0.02% 573
2025
Q3
$231M Buy
1,601,806
+375,069
+31% +$45.9M 0.02% 736
2025
Q2
$123M Sell
1,226,737
-126,262
-9% -$9.65M 0.01% 1040
2025
Q1
$103M Buy
1,352,999
+245,333
+22% +$18.8M 0.01% 1055
2024
Q4
$76.5M Sell
1,107,666
-46,232
-4% -$3.33M 0.01% 1212
2024
Q3
$84.2M Buy
1,153,898
+34,690
+3% +$2.56M 0.01% 1175
2024
Q2
$75M Buy
1,119,208
+123,080
+12% +$4.77M 0.01% 1187
2024
Q1
$27M Sell
996,128
-47,703
-5% -$1.34M ﹤0.01% 1989
2023
Q4
$32.3M Sell
1,043,831
-165,195
-14% -$4.28M ﹤0.01% 1703
2023
Q3
$30.5M Buy
1,209,026
+367,014
+44% +$8.39M ﹤0.01% 1642
2023
Q2
$17.8M Sell
842,012
-142,408
-14% -$2.7M ﹤0.01% 2143
2023
Q1
$16.8M Buy
984,420
+297,959
+43% +$5.79M ﹤0.01% 2297
2022
Q4
$13.7M Buy
686,461
+94,604
+16% +$1.83M ﹤0.01% 2380
2022
Q3
$12.7M Buy
591,857
+49,805
+9% +$1.19M ﹤0.01% 2361
2022
Q2
$10.7M Sell
542,052
-48,066
-8% -$1.01M ﹤0.01% 2627
2022
Q1
$13.9M Buy
590,118
+159,845
+37% +$3.71M ﹤0.01% 2535
2021
Q4
$11.7M Buy
430,273
+50,458
+13% +$1.44M ﹤0.01% 2760
2021
Q3
$10.5M Buy
379,815
+11,916
+3% +$313K ﹤0.01% 2806
2021
Q2
$10.5M Buy
367,899
+151,238
+70% +$4.49M ﹤0.01% 2795
2021
Q1
$7.38M Buy
216,661
+76,603
+55% +$2.93M ﹤0.01% 3010
2020
Q4
$4.66M Sell
140,058
-121,511
-46% -$4.44M ﹤0.01% 3199
2020
Q3
$8.41M Buy
261,569
+88,808
+51% +$2.55M ﹤0.01% 2423
2020
Q2
$4.76M Buy
172,761
+45,284
+36% +$1.07M ﹤0.01% 2867
2020
Q1
$2.04M Buy
127,477
+21,404
+20% +$507K ﹤0.01% 3466
2019
Q4
$2.53M Sell
106,073
-153,881
-59% -$3.13M ﹤0.01% 3838
2019
Q3
$4.58M Buy
259,954
+54,048
+26% +$1.04M ﹤0.01% 3303
2019
Q2
$5.27M Sell
205,906
-1,437
-0.7% -$40K ﹤0.01% 3183
2019
Q1
$6.03M Buy
207,343
+191,206
+1,185% +$4.96M ﹤0.01% 2986
2018
Q4
$211K Sell
16,137
-4,077
-20% -$65.1K ﹤0.01% 5479
2018
Q3
$409K Sell
20,214
-63,891
-76% -$1.44M ﹤0.01% 5092
2018
Q2
$1.99M Buy
84,105
+48,131
+134% +$1.24M ﹤0.01% 3976
2018
Q1
$810K Buy
35,974
+11,516
+47% +$303K ﹤0.01% 4531
2017
Q4
$762K Buy
24,458
+674
+3% +$19.9K ﹤0.01% 4664
2017
Q3
$742K Sell
23,784
-4,162
-15% -$79.3K ﹤0.01% 4704
2017
Q2
$479K Sell
27,946
-5,858
-17% -$100K ﹤0.01% 4912
2017
Q1
$592K Buy
33,804
+22,204
+191% +$342K ﹤0.01% 4780
2016
Q4
$153K Buy
11,600
+8,582
+284% +$117K ﹤0.01% 5443
2016
Q3
$44K Sell
3,018
-5,757
-66% -$72.1K ﹤0.01% 5768
2016
Q2
$86K Buy
8,775
+8,208
+1,448% +$95.8K ﹤0.01% 5595
2016
Q1
$6K Sell
567
-11,126
-95% -$146K ﹤0.01% 6522
2015
Q4
$212K Buy
11,693
+9,911
+556% +$175K ﹤0.01% 5348
2015
Q3
$33K Sell
1,782
-30,272
-94% -$756K ﹤0.01% 6124
2015
Q2
$782K Buy
32,054
+29,953
+1,426% +$680K ﹤0.01% 4319
2015
Q1
$43K Sell
2,101
-4,322
-67% -$76.1K ﹤0.01% 5730
2014
Q4
$100K Buy
6,423
+4,907
+324% +$69.6K ﹤0.01% 5882
2014
Q3
$19K Sell
1,516
-21,445
-93% -$323K ﹤0.01% 7073
2014
Q2
$459K Buy
22,961
+4,212
+22% +$62.4K ﹤0.01% 4722
2014
Q1
$357K Sell
18,749
-2,413
-11% -$45.9K ﹤0.01% 4895
2013
Q4
$361K Buy
21,162
+8,601
+68% +$132K ﹤0.01% 5058
2013
Q3
$196K Sell
12,561
-53,104
-81% -$675K ﹤0.01% 5470
2013
Q2
$786K Buy
+65,665
New +$671K ﹤0.01% 4286

Other funds holding INSM

Bank of America's INSM Position: Q2 2026 in Review

Bank of America reduced its Insmed (INSM) stake by 32% in Q2 2026, selling an estimated $58M and leaving 1,023,114 shares worth $109M. The position accounts for 0.01% of the portfolio, ranked #1122.

Bank of America first reported a position in INSM in Q2 2013 and has held it in 53 quarters since. The position peaked at $300M in Q4 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Bank of America held 1,023,114 shares of Insmed worth $109M as of Q2 2026.
  • Bank of America sold 479,167 Insmed shares in Q2 2026, an estimated $58M.
  • Insmed made up 0.01% of Bank of America's portfolio in Q2 2026, its #1122 holding.
  • Bank of America first reported a position in Insmed in Q2 2013 and has held it in 53 quarters since.
  • Bank of America's Insmed position peaked at $300M in Q4 2025.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.